An expert is one who knows more and more about less and less until he knows absolutely everything about nothing

Saturday, March 10, 2018

FREE ONLINEULTRASOUND COURSES

 Our research-based and practice-proven teaching strategies help you to reach your goals. We won’t overload you with overcrowded slides, complex statistics and endless rows of numbers. Our lectures are fun, inspiring, emotional, practical and rich in examples and cases. How does our 123 approach differ from other approaches?  Each course contains highly...

Friday, March 9, 2018

ACP Recommends Less-Intensive HbA1c Target for T2D No proof of benefit for targets below 7%, new guidelines say

New type 2 diabetes guidelines from the American College of Physicians (ACP) recommend less-intensive blood sugar control for most patients, with a glycated hemoglobin (HbA1c) target between 7% and 8%. "Studies have not consistently shown that intensive glycemic control to HbA1c levels below 7% reduces clinical microvascular events, such as loss or impairment of vision,...

Tuesday, February 14, 2017

‘Magic’ blood test could make bone marrow transplants for blood cancer safer

A blood test could help predict the risk of complication following a bone marrow transplant in some blood cancer patients, according to a new US study. The test could help identify which patients given a transplant are likely to develop a potentially fatal complication, the researchers report in The Journal of Clinical Investigation Insight (link is external) . "The...

Saturday, July 30, 2016

FDA Approves Viekira XR

AbbVie Receives U.S. FDA Approval of Once-Daily Viekira XR (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C NORTH CHICAGO, Ill., July 25, 2016 /PRNewswire/ -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application...

FDA Approves Adlyxin

Sanofi Receives FDA Approval of Adlyxin (lixisenatide) for Treatment of Adults With Type 2 Diabetes PARIS, July 27, 2016 /PRNewswire/ -- Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Adlyxin (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of...

Sunday, July 17, 2016

Novel Therapeutic Advances for Management of Diabetes Mellitus

Diabetes mellitus (DM) has become one of the most challenging health problems in the 21st century. It is a serious public health problem globally, but the good news is that various advances are being made in prevention, detection, and treatment of diabetes. Though prevention is always better than cure, yet sometimes prevention is not possible and the cure seems to take...

Sunday, March 20, 2016

Fascinating Facts About Your Body

Even though you’re around human bodies all day (after all, you have one of your very own), you probably don’t know everything there is to know about them. Each of our bodies are a miracle; it’s amazing they work the way they do, day in and day out. If you thought what our bodies could do before, once you read this list of insane facts about the human body, you’ll be in...


About Blogger:

Hi,I,m Basim from Canada I,m physician and I,m interested in clinical research feild and web development.you are more welcome in our professional website.all contact forwarded to basimibrahim772@yahoo.com.


Let's Get Connected: Twitter | Facebook | Google Plus| linkedin

 

Subscribe to us